Skip to main content

Table 3 Persistence patterns of top five prescribing anti-epileptic drugs as monotherapy

From: Analysis of treatment adherence and cost among patients with epilepsy: a four‐year retrospective cohort study in Pakistan

  Continuers
N (%)
Switchers
N (%)
Discontinuers
N (%)
Levetiracetam** 2042 (54.1) 514 (13.5) 1224 (32.4)
Valproic acid** 1158 (47.8) 814 (33.5) 452 (18.7)
Carbamazepine* 745 (46.3) 299 (18.6) 564 (35.1)
Lamotrigine** 780 (60.6) 203 (15.7) 305 (23.7)
Lacosamide* 614 (57.5) 144 (13.5) 310 (29.0)
Others* 299 (22.6) 280 (21.2) 743 (56.2)
Total* 5638 (49.0) 2254 (19.7) 3598 (31.3)
  1. Phenobarbital, phenytoin, gabapentin, pregabalin and oxcarbazepine were categorized as others AEDs
  2. Total (11,490 N) Patients
  3. *P < 0.05; **P < 0.005